FIELD: immunology. SUBSTANCE: task of invention is developing a method of passive immune protection through mucous membrane. Appropriate composition contains active ingredient and hydroxyapatite in the form of capsules from 0.01 to 1 mcm in size. Composition is applied on mucous surface. EFFECT: initiated IgA class antibody formation. 4 cl, 1 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYNTHETIC POLY-IGA-COMPLEX, PROTEIN, METHOD OF COMPLEX PREPARING, METHOD OF TESTING, METHOD OF PROTECTION | 1991 |
|
RU2124050C1 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2540490C2 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2478400C2 |
| BIOLOGICAL METHOD OF ANALYSIS FOR CONTROL OF QUALITY OF NUTRACEUTICALS AND MEDICATIONS | 2010 |
|
RU2570626C2 |
| METHOD FOR DETERMINATION OF n-3 POLYUNSATURATED FATTY ACID ACTIVITY IN FISH OIL SAMPLE | 2010 |
|
RU2642292C1 |
| CELL BASED QUALITY CONTROL BIOASSAYS FOR NUTRICEUTICAL AND MEDICINAL PRODUCTS | 2013 |
|
RU2662358C2 |
| METHOD AND COMPOSITIONS FOR TREATMENT OF PERSISTING INFECTIONS | 2006 |
|
RU2434641C2 |
| METHODS AND COMPOSITIONS FOR TREATMENT OF PERSISTENT INFECTIONS | 2016 |
|
RU2746383C2 |
| METHODS AND COMPOSITIONS FOR TREATING PERSISTENT INFECTIONS | 2006 |
|
RU2596491C2 |
| ADJUVANT ADDITION TO IMMUNONANOTHERAPEUTIC AGENTS | 2009 |
|
RU2496517C2 |
